CVE-2022-26235
Last modified
CVE-2022-26235 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.. EPSS estimates a 0.18% chance of exploitation in the next 30 days.
Description
A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.
Metrics
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Beckmancoulter | Remisol Advance | <= 2.0.12.1 |
References
- https://pastebin.com/amgw9pE7Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advanceProduct, Vendor Advisory
- https://pastebin.com/amgw9pE7Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advanceProduct, Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-26235?
How severe is CVE-2022-26235?
How do I fix CVE-2022-26235?
Are you affected by CVE-2022-26235?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
